Your browser does not support JavaScript!
COVID-19 : Découvrez les Plans de Continuité d’Activité des entreprises de la biotechnologies

Fabricants distributeurs d'instruments de mesure

389 entreprises et organismes intervenants dans le domaine 'Instruments de mesure', classés par activité.

Rejoignez la communauté
Trouvez du matériel
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Il y a 2 semaines
Perlmutter steps down as Merck R&D lead as early research chief Li steps in
Perlmutter steps down as Merck R&D lead as early research chief Li steps in badams Fri, 10/02/2020 - 08:25 ...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 17/09/2020
Cygnal Therapeutics nabs Merck, Takeda vet Wagner for CMO
Cygnal Therapeutics nabs Merck, Takeda vet Wagner for CMO aalidrus Wed, 09/16/2020 - 10:34 ...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 09/09/2020
Merck posts mixed phase 3 data on chronic cough drug gefapixant
Merck posts mixed phase 3 data on chronic cough drug gefapixant ntaylor Tue, 09/08/2020 - 02:31 ...
www.fiercebiotech.com
Une question a été posée - Le 08/09/2020
2 activité(s)
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 17/07/2020
Merck taps Novocure's cancer-fighting electric fields for new Keytruda combination study
Merck taps Novocure's cancer-fighting electric fields for new Keytruda combination study chale Thu, 07/16/2020 - 10:36 ...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 27/05/2020
Merck inks Themis buyout to join COVID-19 vaccine race
Merck inks Themis buyout to join COVID-19 vaccine race ntaylor Tue, 05/26/2020 - 05:54 ...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 13/05/2020
Skyhawk Therapeutics boosts Merck collab pact with added targets, upfront and biobucks
Merck has decided to double down on its research pact with startup Skyhawk Therapeutics as it expands the deal to now also cover autoimmune and metabolic diseases....
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 29/04/2020
Merck, slower than its peers, edges into COVID-19 fight
Almost all of Merck’s Big Pharma peers have either on their own or, increasingly, with a partner, geared up to fight the good fight against COVID-19....
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 28/04/2020
Merck joins Seattle consortium to uncover the coronavirus’ molecular workings
Merck & Co. has begun working with the non-profit Institute for Systems Biology and a consortium of companies to investigate the molecular mechanisms behind the novel coronavirus, in a bid to...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 16/04/2020
Lawrence lands Cardurion CEO job after helping ArQule to Merck buyout
Peter Lawrence has taken up the CEO job at Cardurion Pharmaceuticals, a Takeda-partnered biotech that is moving a heart failure drug through the clinic. Lawrence landed the gig on the strength of a...
www.fiercebiotech.com
Charger plus d'actualités